Surgical Robotic Systems Market (2026 - 2033)

Surgical Robotic Systems Market Summary

The global surgical robotic systems market size was valued at USD 14.1 billion in 2025 and is projected to grow from USD 17.2 billion in 2026 to USD 45.6 billion by 2033, at a CAGR of 14.9% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 47.0% in 2025.

Market Dynamics

Market Concentration & Characteristics

The surgical robotic systems market demonstrates a high degree of innovation, driven by advancements in artificial intelligence (AI), robotic navigation, computer vision, haptic feedback, and digital surgery platforms. Manufacturers are integrating AI-enabled planning, intraoperative imaging, and data analytics to improve surgical precision, workflow efficiency, and clinical outcomes. For instance, in October 2025, Johnson & Johnson MedTech announced the integration of AI-driven simulation into its MONARCH Platform for Urology, enabling virtual operating room simulations that assist clinical teams in configuring robotic systems before procedures.

“With AI-driven simulation, we can create high-fidelity digital twins that adhere to the laws of physics, can simulate the real world, and ultimately unlocks physical AI capabilities. As we launch new robotics technologies and continue accelerating our innovation pipeline, these simulations have the potential to enhance our differentiated technology development in support of our mission to deliver better patient outcomes.”-Neda Cvijetic, Senior Vice President, Global Head of Robotics & Digital R&D, MedTech, Johnson & Johnson

The industry is experiencing a moderate level of merger and acquisition activities as manufacturers seek to strengthen robotic technology portfolios, expand clinical applications, and accelerate innovation. Companies are acquiring developers specializing in robotic navigation, imaging, artificial intelligence, and digital surgery software to enhance integrated surgical ecosystems.

The impact of regulations is high, as surgical robotic systems must comply with stringent medical device regulations and clinical safety requirements before commercialization. Regulatory agencies, including the U.S. Food and Drug Administration (FDA), the European Commission under the Medical Device Regulation (EU MDR 2017/745), the UK Medicines and Healthcare Products Regulatory Agency (MHRA), Health Canada, and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), require extensive premarket evaluation, clinical validation, software verification, cybersecurity assessment, quality management system compliance, and post-market surveillance. These regulatory requirements ensure device safety, effectiveness, and long-term performance but also increase development costs and extend product approval timelines.

The market is witnessing a high level of product expansion as manufacturers broaden robotic platforms across multiple surgical specialties, including general surgery, Orthopedic Surgery, spine, bronchoscopy, thoracic surgery, and urology. Companies are also expanding their portfolios through next-generation robotic systems, advanced instruments, disposable accessories, and AI-enabled software modules.

Analyst Perspective

The surgical robotic systems market is evolving from standalone premium platforms toward integrated ecosystems combining robotics, AI-enabled navigation, imaging, instruments, software, and lifecycle services. Growth is driven by rising demand for minimally invasive surgery, increasing procedure volumes, broader specialty adoption, and expanding use across hospitals and ambulatory surgical centers. Providers now evaluate systems based on clinical outcomes, procedural efficiency, cost-effectiveness, interoperability, surgeon training, and service support-rather than hardware alone-creating opportunities for both established players and emerging companies offering modular, compact, cost-efficient solutions. Companies with strong clinical evidence, digital integration, recurring accessory and service revenue, and scalable surgeon education programs are best positioned to capture future growth.

Component Insights

The surgical robotic accessories segment led the surgical robotic systems market with the largest share of 53.6% in 2025, driven by recurring demand for robotic instruments, consumables, staplers, vessel sealers, scissors, and imaging accessories used in robotic-assisted procedures. Rising procedure volumes across urology, gynecology, thoracic, and general surgery continue to support segment growth. For instance, in July 2025, Intuitive Surgical received U.S. FDA clearance for its Vessel Sealer Curved instrument for da Vinci systems, supporting improved surgical precision and broader use of robotic-assisted procedures.

The surgical robotic services segment is expected to register the fastest growth during the forecast period. Growth is driven by the expanding installed base of surgical robots across hospitals and ambulatory surgical centers, increasing demand for installation, maintenance, software upgrades, technical support, and surgeon training. Regular servicing helps maintain system performance, reduce downtime, and support regulatory compliance.

Application Insights

The general surgery segment dominated the surgical robotic systems industry with the largest share of 28.7% in 2025, driven by high procedure volumes across colorectal, gastrointestinal, hepatobiliary, and hernia surgeries. Robotic-assisted systems offer enhanced 3D visualization, improved dexterity, and greater surgical precision, supporting better outcomes, shorter hospital stays, and faster recovery.

The Neurosurgery segment is expected to register the fastest growth during the forecast period, supported by rising demand for minimally invasive brain and spine procedures. Advancements in AI-enabled navigation, real-time imaging, and robotic-assisted microsurgery are improving procedural accuracy and expanding adoption in complex neurological applications. For instance, in May 2026, MMI’s Symani Surgical System was used to treat the first patient with Alzheimer’s in the FDA-approved REMIND clinical study, highlighting the growing role of robotic-assisted precision systems in Neurosurgery.

End-use Insights

The inpatient segment dominated the market with a revenue share of 72.0% in 2025, as healthcare facilities are increasingly adopting robotic technology, advanced robotic instruments, and accessories to enhance medical procedures. These advanced robots offer precision, minimally invasive techniques, and improved patient outcomes. In January 2025, Prashanth Hospitals inaugurated the Institute of Robotic Surgery, introducing a medical robotic system designed for minimally invasive surgeries. With its features designed to enhance precision and patient safety, along with its applicability across various specialties, this innovation is expected to transform how surgeries are performed.

The outpatient segment is anticipated to grow at the fastest CAGR over the forecast period. These facilities offer patients minimally invasive, highly precise surgeries, resulting in shorter recovery times and reduced healthcare costs. The growing trend towards outpatient robotic surgeries strengthens the industry's commitment to providing accessible, efficient, and patient-centric medical solutions outside traditional hospital settings.

Regional Insights

North America dominated the surgical robotic systems market with the largest revenue share of 47.0% in 2025. High procedural volumes, a growing geriatric population, and a high burden of chronic diseases are primary factors driving the North America medical and healthcare robotics market. The U.S. performs a substantial number of surgical procedures, including orthopedic, neurological, cardiovascular, and oncologic interventions, in which robotic-assisted systems improve precision and reduce complications.

Moreover, Canada’s publicly funded healthcare system is expanding minimally invasive surgery programs to manage wait times and improve outcomes, supporting the adoption of surgical robots. In Mexico, rising private healthcare investment and medical tourism are accelerating the uptake of advanced surgical technologies in tertiary hospitals.

U.S. Surgical Robotic Systems Market Trends

The U.S. surgical robotic systems industry is expected to grow significantly over the forecast period. High surgical volumes, favorable reimbursement, and strong clinical preference for minimally invasive procedures are driving the adoption of surgical robotics in the U.S. For instance, in March 2026, Golden Valley Memorial Healthcare completed the world's first knee replacement using THINK Surgical's TMINI miniature robotic system with Stryker Triathlon Knee implants. Similarly, in March 2026, Novant Health launched a robotic mitral valve repair program through its Heart & Vascular Institute. This expanded access to minimally invasive heart surgery across the Carolinas at specialized centers, improving patient outcomes through advanced robotic precision.

“This program represents a significant step forward for Novant Health and for patients across the Carolinas. Robotic mitral valve repair strengthens our ability to provide leading-edge, minimally invasive heart care. It reinforces our position as a destination for complex cardiac surgery and reflects our ongoing investment in innovation that benefits our patients.”-Howard L. Haronian, MD, FACC, physician in chief of the Novant Health Heart & Vascular Institute.

Europe Surgical Robotic Systems Market Trends

The Europe surgical robotic systems industry is growing rapidly, driven by increasing adoption of AI-integrated surgical platforms that combine planning, navigation, and robotic execution to improve surgical precision, efficiency, and patient outcomes. This growth is further supported by the EU Medical Device Regulation (EU MDR) framework, which ensures standardized approval and safe deployment of advanced robotic systems across diverse healthcare systems.

The surgical robotic systems market in the UK is expected to grow over the forecast period. The rapid expansion of robotic systems across the National Health Service, with significant growth in hospital adoption and procedure volumes, is driving market growth by enhancing surgical precision, efficiency, and clinical outcomes. In March 2026, a study published in Surgical Endoscopy reported that adoption of robotic-assisted surgical systems across the National Health Service increased from 20% of trusts in 2014 to 67% in 2024, with procedure volumes rising from 3,622 to 36,209. This strong growth trajectory highlights increasing clinical acceptance and is expected to further accelerate the integration of robotic technologies across surgical specialties in the UK.

The Germany surgical robotic systems market held the largest share of Europe in 2025. Rising investments in AI-driven surgical decision-support technologies are accelerating the advancement of healthcare robotics in Germany. For instance, in May 2025, Medical Decision Alliance secured €3.3 million (USD 3.56 million) in seed funding to develop AI-powered systems that provide real-time, expert-guided support during surgical procedures. Such innovations enhance the intelligence and clinical capabilities of robotic platforms, enabling improved decision-making, precision, and outcomes. This trend reflects growing investor confidence and is expected to drive the integration of AI with surgical robotics, supporting next-generation smart operating environments in Germany.

Asia Pacific Surgical Robotic Systems Market Trends

The Asia Pacific surgical robotic systems industry is expected to grow at the fastest CAGR during the forecast period. The increasing deployment of AI-integrated surgical robotics in emerging Asia Pacific healthcare systems is driving market growth by improving surgical precision, reducing costs, and expanding access to advanced procedures in Orthopedic Surgery and general surgery. In April 2025, Vinmec Healthcare System introduced a robotic-assisted knee replacement system in Vietnam, enabling cost-effective joint replacement surgery with enhanced precision and faster patient recovery outcomes, further driving the growth of robots for better precision surgery.

The Japan surgical robotic systems market is depicting technologically advanced products launched by key players drive the growth of the market. The convergence of AI is accelerating the evolution of next-generation robotic systems by enabling higher adaptability, precision, and automation efficiency through real-time intelligent decision-making. In March 2026, FANUC announced a collaboration with NVIDIA to develop “physical AI”- enabled robotic systems using NVIDIA Jetson, Omniverse, and Isaac Sim platforms, enabling manufacturers to train, simulate, and deploy intelligent robots through digital twins, significantly improving automation flexibility, production efficiency, and operational scalability.

The surgical robotic systems market in China held the largest revenue share in 2025. The growing development of AI-driven, multi-specialty surgical robotics platforms is accelerating innovation and competition in the global healthcare robotics market by enabling integrated, cross-disciplinary surgical capabilities and expanding remote and precision-assisted surgery applications. In December 2025, Tuodao Medical Technologies launched its surgical robotics platform in China, developing AI- and data-driven robotic systems targeting multiple specialties, including Orthopedic Surgery, urology, gynecology, general surgery, respiratory medicine, and imaging, while also announcing plans to build an integrated remote intelligent medical center and expand globally through partnerships with leading medical institutions.

Latin America Surgical Robotic Systems Market Trends

The Latin America surgical robotic systems industry is anticipated to grow at a significant CAGR over the forecast period. Rising investment in healthcare infrastructure and gradual modernization of hospital systems are key drivers in Latin America. Countries such as Brazil and Argentina are expanding private healthcare networks and upgrading surgical capabilities to improve clinical outcomes. Adoption of surgical robots is increasing in large urban hospitals seeking to enhance precision and attract medical tourism. Moreover, growing demand for advanced medical procedures and improving access to healthcare services are further supporting market growth.

Middle East and Africa Surgical Robotic Systems Market Trends

The Middle East and Africa surgical robotic systems industry is expected to grow at a significant CAGR over the forecast period. Strong government initiatives to modernize healthcare infrastructure are a primary driver in the Middle East & Africa region. Countries such as Saudi Arabia, the UAE, and South Africa are investing heavily in advanced medical technologies as part of broader healthcare transformation programs. Surgical robots are being deployed in leading hospitals to enhance clinical capabilities and position institutions as regional centers of excellence.

Key Surgical Robotic Systems Company Insights

Key players operating in the surgical robotic systems market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as new product launches and partnerships are playing a key role in propelling the market growth.

Key Surgical Robotic Systems Companies:

The following key companies have been profiled for this study of the surgical robotic systems market.

• Medtronic

• Intuitive surgical

• MICROPORT SCIENTIFIC

• SS Innovations

• Stryker

• Johnson & Johnson

• Asensus Surgical US, Inc. | Part of KARL STORZ

• Distalmotion

• CMR Surgical

• Moon Surgical

• Medicaroid

• Ronovo Surgical

• Cornerstone Robotics

Competitive Benchmarking

Recent Developments

• In September 2026, Enovis entered into a binding offer to acquire eCential Robotics for Euro 155 million (USD 180 million), strengthening its ASTRA enabling technology platform with robotic automation capabilities and supporting the development of next-generation orthopedic surgical robots, initially targeting knee and subsequently shoulder procedures.

• In July 2026, Johnson & Johnson received U.S. FDA De Novo authorization for the OTTAVA Robotic Surgical System, a table-integrated soft tissue robotic system indicated for multiple general surgery procedures, including gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, and appendectomy.

• In April 2026, Stäubli Robotics launched the TX2-60L MedX Ready medical robot, a high-precision six-axis system designed for surgical and clinical applications, offering enhanced safety, reliability, and intuitive manual guidance for advanced medical device integration.

• In April 2026, SS Innovations launched next-generation surgical robotic technologies, including the SSi Vimana Aero drone system and SSi Avtara humanoid platform, highlighting advancements in remote surgery, battlefield care, and mobile robotic operating environments at SMRSC 2026.

“Innovation is in our DNA. Beyond continuously improving our advanced, cost-effective SSi Mantra surgical robotic system and telesurgery capabilities, we strive to pioneer new surgical robotic technologies that will meaningfully improve healthcare for a wider segment of patients in need. SMRSC 2026, our largest conference yet, successfully elevated this important theme.”

-Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations

• In February 2026, Stryker introduced the Mako RPS handheld robotic system for total knee procedures, expanding its Mako robotics portfolio and enabling enhanced surgical precision through an intuitive, robotically guided power tool integrated with its SmartRobotics platform.

• In February 2026, Medtronic received FDA 510(k) clearance for the Stealth AXiS surgical system, an integrated platform combining AI-based planning, real-time navigation, and robotic assistance for spine surgery.

"One of the biggest challenges in spine surgery has been understanding and responding to how the spine moves during a procedure. The Stealth AXiS system gives surgeons real-time visibility into that motion, helping us more consistently achieve our surgical plan without interrupting workflow. To me, this is truly game changing technology."

• In September 2025, Siemens Healthineers and Stryker announced a strategic partnership to develop a first-of-its-kind robotic system for comprehensive neurovascular procedures, including stroke and aneurysm treatments. Combining Siemens' robotics/imaging expertise with Stryker's neurovascular devices, it aims to enhance precision, workflow efficiency, and patient outcomes in elective/emergency interventions.

Surgical Robotic Systems Market Report Scope

Global Surgical Robotic Systems Market Report Segmentation

This report forecasts revenue & volume growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global surgical robotic systems market report based on component, application, end-use, and region:

• Component Outlook (Revenue, USD Million, 2021 - 2033)

  • Surgical Robots

  • Surgical Robotic Accessories

  • Surgical Robotic Services

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • General Surgery

  • Gynecology

  • Urology

  • Orthopedic Surgery

    • Hip

    • Knee

    • Spine

    • Others

  • Neurosurgery

  • Cardiac Surgery

  • Bariatric

  • Bronchoscopy/Pulmonary

  • Others

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Inpatient

  • Outpatient

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The surgical robotic systems market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each surgical robotic systems segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Market-specific Research Models

Consensus-Based Estimates & Forecasting

The surgical robotic systems market presents emerging to dominant opportunities, featuring global key players such as Medtronic; Intuitive Surgical; MICROPORT SCIENTIFIC; SS Innovations; Stryker; Johnson & Johnson; Asensus Surgical US, Inc. | Part of KARL STORZ; Distalmotion; CMR Surgical; Moon Surgical; Medicaroid; Ronovo Surgical; Cornerstone Robotics. To ensure a holistic approach, the GVR research team adopted a comprehensive methodology, considering multiple companies worldwide and utilizing various variables for data accuracy.

Our methodology included:

Model 1: Commodity Flow Analysis - For public players, annual reports were referenced. For private players, premium paid data sources such as S&P Global, Crunchbase, ZoomInfo, RocketReach, etc., were used for the latest revenue insights.

Model 2: Parent Market Analysis

Model 3: Country-level Multivariate Analysis Assumptions

Model 4: Segment-level Multivariate Analysis Assumptions

Model 5: Surgical Robotic Systems Market CAGR Calculations

Customization Table